Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Neuronetics, Inc.

Neuronetics, Inc. (STIM) Stock Overview

Explore Neuronetics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

STIM●NASDAQ
HealthcareMedical - Devices
$3.00
$0.09(2.91%)
U.S. Market opens in 58h 45m

Neuronetics, Inc. (STIM)

Meyka AI Score

Z

Key Financials

Market Cap208.8M
P/E Ratio-6.99
EPS (TTM)$-0.44
ROE-1.51%
Fundamental Analysis

AI Price Forecasts

1 Month$2.42
3 Months$0.28
1 Year Target$1.95

STIM Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Neuronetics, Inc. (NASDAQ: STIM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Neuronetics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of STIM on the NASDAQ shows an RSI of 64.61, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $1.95 for the NASDAQ listing.

Key metrics behind Neuronetics, Inc.'s NASDAQ-traded stock include a P/E ratio of -6.99 and a market capitalization of 208.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of STIM on the NASDAQ.

Price Performance (NASDAQ: STIM)

1-Day Change
-2.91%
5-Day Change
-1.96%
1-Month Change
59.57%
3-Month Change
152.10%
6-Month Change
132.56%
Year-to-Date (YTD) Change
117.39%
1-Year Change
-11.24%
3-Year Change
82.93%
5-Year Change
-61.88%
All-Time (Max) Change
-89.20%

Contact Information

https://www.neurostar.com
610 640 4202
3222 Phoenixville Pike, Malvern, PA, 19355

Company Facts

6,580 Employees
IPO DateJun 28, 2018
CountryUS
Actively Trading

Frequently Asked Questions